Positron (OTCBB: POSC) May Get a Boost from PET Scanning of Lymphoma Patients
In a recent online edition of Clinical Oncology, PET scanning is introduced for the first time as a standardized method to assess the progression of a patient’s lymphoma treatment. This marks the first time that the standards have been revisited on an international scale. PET imaging, in contrast to traditional CT scanning, can discern the difference between a tumor and scar tissue left behind after a successful surgery. The efficacy of the scanning allows for a definitive diagnosis in both cases of there being no tumor or the presence of one. This will allow for greater speed in treatment for…